back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-23 09:47 Tx date 2024-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-9,310 vol |
0 | |
| Filed 2024-05-23 09:21 Tx date 2024-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,058 vol |
28,141 | |
| Filed 2024-05-23 09:19 Tx date 2024-05-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-9,310 vol |
||
| Filed 2023-05-24 14:24 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
156,193 | |
| Filed 2023-05-24 14:17 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,083 vol |
24,083 | |
| Filed 2023-05-24 14:13 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
| Filed 2023-05-24 14:02 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
| Filed 2023-05-24 14:01 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
||
| Filed 2022-05-23 11:02 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
140,959 | |
| Filed 2022-05-23 10:59 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
| Filed 2022-05-23 10:58 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-17 16:59 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
126,347 | |
| Filed 2020-06-16 11:47 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
95,000 | |
| Filed 2020-06-03 14:40 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
| Filed 2020-06-03 14:40 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
95,000 | |
| Filed 2019-07-05 13:02 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
65,000 | |
| Filed 2019-05-03 20:07 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$422,499
+50,000 vol $8.45 each |
50,000 | |
| Filed 2019-05-03 20:02 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-03 20:00 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 |